Literature DB >> 7891376

Genetic epidemiology of early onset breast cancer.

D Eccles1, A Marlow, G Royle, A Collins, N E Morton.   

Abstract

Risks for breast cancer when there is a family history of the disease are usually calculated using data from segregation analyses which favour a single dominant gene with high penetrance. There are, however, at least three loci known to be associated with familial breast cancer (p53, BRCA1, and an as yet unpublished locus) and the frequencies and penetrances of these genes are not likely to be the same. We have attempted to address the problem of which genetic parameters should be used to calculate risks for different patterns of familial breast cancer. Data from 384 nuclear families ascertained through a proband selected for early onset breast cancer were subjected to complex segregation analysis, correcting for ascertainment bias resulting from selection for severe phenotype. Age of onset of breast cancer, incorporated as severity, provides additional information to the segregation model over and above that given by assigning liability classes on the basis of age at observation. The use of this additional parameter in the analysis is described. There is fair agreement between estimates from this sample and previous predictions from consecutive probands and consultands. The differences suggest more than one rare dominant gene for susceptibility to breast cancer, with different penetrances. Although refinements of segregation analysis will help to delineate these different genes, perfect resolution will require identification of the mutant alleles. Methods to estimate genetic parameters under genotype specific mortality need to be developed. Meanwhile, we suggest that high and low estimates of penetrance be used in risk estimation for genetic counselling, and as a guide to candidates for entry into clinical trials of screening and chemoprevention in breast cancer.

Entities:  

Mesh:

Year:  1994        PMID: 7891376      PMCID: PMC1016695          DOI: 10.1136/jmg.31.12.944

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  10 in total

1.  Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families.

Authors:  B Newman; M A Austin; M Lee; M C King
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

2.  Genetic epidemiology of complex phenotypes.

Authors:  N E Morton; D C Shields; A Collins
Journal:  Ann Hum Genet       Date:  1991-10       Impact factor: 1.670

3.  Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE.

Authors:  K Lange; D Weeks; M Boehnke
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

4.  Ascertainment in the sequential sampling of pedigrees.

Authors:  C Cannings; E A Thompson
Journal:  Clin Genet       Date:  1977-10       Impact factor: 4.438

5.  Prediction of genetic risks from segregation analyses of morbid risks.

Authors:  D C Shields; A J Marlow; R S Houlston; D M Eccles; N E Morton
Journal:  Hum Hered       Date:  1994 Jan-Feb       Impact factor: 0.444

6.  Family history and risk of breast cancer.

Authors:  R S Houlston; E McCarter; S Parbhoo; J H Scurr; J Slack
Journal:  J Med Genet       Date:  1992-03       Impact factor: 6.318

7.  Linkage of early-onset familial breast cancer to chromosome 17q21.

Authors:  J M Hall; M K Lee; B Newman; J E Morrow; L A Anderson; B Huey; M C King
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

8.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

9.  Genetic epidemiology of breast cancer in Britain.

Authors:  L Iselius; J Slack; M Littler; N E Morton
Journal:  Ann Hum Genet       Date:  1991-05       Impact factor: 1.670

10.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

  10 in total
  8 in total

1.  After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.

Authors:  J Cui; A C Antoniou; G S Dite; M C Southey; D J Venter; D F Easton; G G Giles; M R McCredie; J L Hopper
Journal:  Am J Hum Genet       Date:  2000-12-27       Impact factor: 11.025

2.  Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG).

Authors:  D M Eccles; D G Evans; J Mackay
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

3.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

Authors:  A Antoniou; P D P Pharoah; S Narod; H A Risch; J E Eyfjord; J L Hopper; N Loman; H Olsson; O Johannsson; A Borg; B Pasini; P Radice; S Manoukian; D M Eccles; N Tang; E Olah; H Anton-Culver; E Warner; J Lubinski; J Gronwald; B Gorski; H Tulinius; S Thorlacius; H Eerola; H Nevanlinna; K Syrjäkoski; O-P Kallioniemi; D Thompson; C Evans; J Peto; F Lalloo; D G Evans; D F Easton
Journal:  Am J Hum Genet       Date:  2003-04-03       Impact factor: 11.025

4.  A novel duplication polymorphism in the FANCA promoter and its association with breast and ovarian cancer.

Authors:  Ella Thompson; Rebecca L Dragovic; Sally-Anne Stephenson; Diana M Eccles; Ian G Campbell; Alexander Dobrovic
Journal:  BMC Cancer       Date:  2005-04-29       Impact factor: 4.430

5.  BRCA1 mutations in southern England.

Authors:  D M Eccles; P Englefield; M A Soulby; I G Campbell
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

6.  No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer.

Authors:  Ian G Campbell; David Choong; Georgia Chenevix-Trench
Journal:  Breast Cancer Res       Date:  2004-05-14       Impact factor: 6.466

7.  The DNMT3B C-->T promoter polymorphism and risk of breast cancer in a British population: a case-control study.

Authors:  Karen G Montgomery; Mira C P Liu; Diana M Eccles; Ian G Campbell
Journal:  Breast Cancer Res       Date:  2004-05-19       Impact factor: 6.466

8.  No Association of Early-Onset Breast or Ovarian Cancer with Early-Onset Cancer in Relatives in BRCA1 or BRCA2 Mutation Families.

Authors:  Marion Imbert-Bouteille; Carole Corsini; Marie-Christine Picot; Lucas Mizrahy; Sandrine Akouete; Helena Huguet; Frédéric Thomas; David Geneviève; Patrice Taourel; Marc Ychou; Virginie Galibert; Chloé Rideau; Karen Baudry; Tatiana Kogut Kubiak; Isabelle Coupier; Rémy Hobeika; Yvette Macary; Alain Toledano; Jérôme Solassol; Antoine Maalouf; Jean-Pierre Daures; Pascal Pujol
Journal:  Genes (Basel)       Date:  2021-07-20       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.